The success of any company is through its management and leadership. MDI has a team of dedicated and experienced management specialists who seek new business opportunities and operate an efficient and profitable company. The company is overseen by its Board of Directors who offer an extensive knowledge base across business, finance and the health industry, who together, make the necessary decisions for the welfare of MDI’s shareholders and the growth of the company.
Chief Executive Officer
Group Financial Controller/Company Secretary
Director of Scientific Affairs
Associate Director – Commercial
Quality Assurance and Validation Manager
General Manager – Sales & Marketing
Director of Research & Operations
Board of Directors
Mr. David Williams, B.Ec (Hons), M.Ec, FAICD
David is Managing Director of Kidder Williams Ltd, with over 26 years experience in the investment banking sector.
Mr. Allan McCallum, Dip.Ag.Science, MAICD
Allan is Chairman of Tassal Group Limited, Non-Executive Director of Incitec Pivot Limited, and Chairman of CRF Group Ltd. Allan was formerly Chairman of Vicgrain Ltd ,Deputy Chairman of Graincorp Ltd, Chairman of Access Genetics Pty Ltd and Nugrain Pty Ltd.
Dr. Harry Oxer, AM, ASM, KStJ, MA (Hons), MB.BChir (Cantab), MRCS.LRCP, DA, FFARCS, FRCA, FFARACS, FANZCA, FACAP, DipDHM
Harry is a Medical Consultant to St John Ambulance in Western Australia. Harry is a member of the State Executive for St John Ambulance (WA), and was the previous Medical Director for twenty-six years.
He has taught, lectured and published extensively over the years, both nationally and internationally. Harry is also a past Chairman of the Australian Resuscitation Council and has a major interest in resuscitation, oxygen therapy, and pain relief.
Mr. Max Johnston
Max was appointed a Director of the company with effect from November 2012. Max is a non-executive director of Enero Group Limited and Probiotec Limited.
For 11 years he was President and Chief Executive Officer of Johnson & Johnson Pacific and an Executive Director of Johnson & Johnson.
Max has also held several prominent industry roles as a past President of ACCORD Australasia Limited, a former Vice Chairman of the Australian Food and Grocery Council and a former member of the board of ASMI. Max has had extensive overseas experience during his career in leading businesses in both Western and Central-Eastern Europe, Africa as well as Asia- Pacific.
Mr Hoare is the Managing Director of Lohmann & Rauscher (Australia and New Zealand), a privately owned, multinational medical device company. Previously, Mr Hoare was Managing Director of Smith & Nephew (Aus/NZ) until the end of 2015, one of Smith and Nephew’s largest global subsidiaries outside the USA. He served as President of Smith & Nephew’s Asia Pacific Advanced Wound Management (AWM) business for 5 years and was a member of the Global Executive Management for the AWM Division. In his 24 years with Smith & Nephew, he also held roles in Marketing, Divisional and General Management. Mr Hoare’s career also included a senior role at Bristol-Myers Squibb in surgical products, and Vice-Chair of Australia’s peak medical device body, Medical Technology Association of Australia. Leon is also a Non-executive Director of PolyNovo Limited (ASX: PNV).
Leon’s 30 years of healthcare industry experience, spanning multiple medical technologies, and management of all aspects of a major market-leading medical device company, coupled with extensive experience in Asia, will add depth to the Board of Directors.
Philip, a Chartered Accountant, has an extensive finance background and commenced working in investment banking in 1996 at Hambros Corporate Finance following ten years industry experience in senior finance roles with ASX listed public company OAMPS Limited. Prior to these roles, Philip worked for ten years within the Assurance Division at Arthur Andersen & Co.
From January 2006 to July 2013 Philip was an Executive Director at Corporate Finance Advisory firm Kidder Williams. Philip is also a Director of PolyNovo Limited (ASX:PNV).
Philip is also Chairman of the MDI Audit and Risk Committee.